Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Histone Methylation Silences Genes

By Biotechdaily staff writers
Posted on 12 Nov 2002
Researchers have established a link between histone methylation and Polycomb group proteins (PcG)-mediated gene silencing in the developing embryo. More...
This finding was reported in the November 1, 2002, issue of Science.

Gene silencing is crucial for normal embryonic development. When the developing embryo no longer requires the products of a particular gene, that gene must be permanently turned off (silenced). The Hox genes, which are expressed in early embryonic development and then silenced by the action of proteins produced by the Polycomb group of genes, have been of particular interest. Embryos from animals with mutated or missing Polycomb genes fail to silence the Hox genes, and the embryos do not develop normally.

In the current study, investigators from the University of North Carolina School of Medicine (Chapel Hill, USA) described the purification and characterization of a Polycomb group protein complex. "Basically, we found that the Polycomb proteins function through methylating a particular lysine residue, lysine 27, on histone 3,” explained senior author Dr. Yi Zhang, UNC assistant professor of biochemistry and biophysics.

When enzyme activity causing methylation of this site is blocked, Hox gene silencing does not occur. The permanent silencing of the Hox genes was explained by the observation that histone methylation cannot be reversed. In Dr. Zhang's words, "Thus far, no ‘histone demethylase' has been discovered.”



Related Links:
Univ. of NC School of Medicine

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.